跳至主要内容
临床试验/EUCTR2007-005365-35-FR
EUCTR2007-005365-35-FR进行中(未招募)1 期

Multicenter, parallel, controlled, randomized, single blind clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertension treated with continous ambulatory or automated peritoneal dialysis. - PDOne

Gambro Lundia AB0 个研究点目标入组 158 人开始时间: 2008年8月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
158

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Chronic renal failure
  • - Stable patients on CAPD with a minimum of 3 bag exchanges including at least one 4-6 hour dwell or patients on APD with at least one daytime exchange lasting for at least 4-6 hours
  • - Hypertensive patients with high blood pressure at inclusion (Office SBP =140 mmHg and/or DBP =90 mmHg) or hypertensive patients receiving antihypertensive medication, including diuretics, disregarding blood pressure values.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Low blood pressure (Office sitting SBP =120 mmHg and confirmed by ABPM =105 mmHg mean SBP)
  • - Symptomatic or asymptomatic ortostatic hypotension (defined as a fall in systolic OBP of at least 20 mmHg after standing for at least 1 minute)
  • - Urine volume >1500ml/24h
  • - Natremia <130 mmol/l, after two consecutive measurements
  • - Peritonits within one month prior to study start
  • - Exite site and/or tunnel infection
  • - Patients unable to tolerate 2 L bag exchanges
  • - Patients with implantable electric device (pace-maker..)

研究者

相似试验

进行中(未招募)
1 期
Clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertensioSubjects with renal failure treated with peritoneal dialysisMedDRA version: 17.0Level: LLTClassification code 10009119Term: Chronic renal failureSystem Organ Class: 100000004857
EUCTR2007-005365-35-DEFresenius Medical Care Deutschland GmbH140
进行中(未招募)
不适用
Investigate if a peritoneal dialysis solution with less sodium can improve blood pressure and overhydration when treated on peritoneal dialysis.Patients with chronic renal disease treated on peritoneal dialysis and diagnosed for hypertension.MedDRA version: 14.1Level: PTClassification code 10034660Term: Peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10067974Term: Automated peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10064116Term: Continuous ambulatory peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2007-005365-35-GBFresenius Medcial Care Deutschland GmbH140
进行中(未招募)
不适用
Clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertensioSubjects with renal failure treated with peritoneal dialysisMedDRA version: 17.0Level: LLTClassification code 10009119Term: Chronic renal failureSystem Organ Class: 100000004857
EUCTR2007-005365-35-SEFresenius Medical Care Deutschland GmbH140
进行中(未招募)
1 期
Clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertensio
EUCTR2007-005365-35-DKFresenius Medical Care Deutschland GmbH140
进行中(未招募)
不适用
Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients - SPaRCLeMedDRA version: 9.1Level: LLTClassification code 10004939Term: Bipolar I disorderBipolar I Disorder
EUCTR2004-000915-25-LTAstraZeneca R&D Sodertalje2,100